(Q48224419)

9 February 2018

title

Cardioprotection for Duchenne's muscular dystrophy. (English)

1 reference

9 February 2018

author name string

Ishikawa Y

series ordinal

1

1 reference

9 February 2018

Bach JR

series ordinal

2

1 reference

9 February 2018

Minami R

series ordinal

3

1 reference

9 February 2018

language of work or name

English

0 references

publication date

1 May 1999

1 reference

9 February 2018

published in

American Heart Journal

1 reference

9 February 2018

volume

137

1 reference

9 February 2018

issue

5

1 reference

9 February 2018

page(s)

895-902

1 reference

9 February 2018

Duchenne muscular dystrophy: patterns of clinical progression and effects of supportive therapy

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970414-X

Prospective study of X-linked progressive muscular dystrophy in Campania

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970414-X

End of life care in Duchenne muscular dystrophy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970414-X

Cardiovascular considerations in the management of neuromuscular disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970414-X

Update and perspectives on noninvasive respiratory muscle aids. Part 1: The inspiratory aids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970414-X

Update and perspective on noninvasive respiratory muscle aids. Part 2: The expiratory aids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970414-X

Prevention of pulmonary morbidity for patients with Duchenne muscular dystrophy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970414-X

Evaluation of myocardial damage in Duchenne's muscular dystrophy with thallium-201 myocardial SPECT

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970414-X

Gated radionuclide ventriculography in the evaluation of cardiac function in Duchenne's muscular dystrophy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970414-X

Biochemical detection of left-ventricular systolic dysfunction.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970414-X

Different secretion patterns of atrial natriuretic peptide and brain natriuretic peptide in patients with congestive heart failure.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970414-X

Brain natriuretic peptide is a sensitive indicator of impaired left-ventricular function in elderly patients with cardiovascular disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970414-X

Plasma brain natriuretic peptide in assessment of acute dyspnoea.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970414-X

Secretion and clinical significance of atrial natriuretic peptide in patients with muscular dystrophy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970414-X

Changes in cardiac beta-adrenoceptors in human heart diseases: relationship to the degree of heart failure and further evidence for etiology-related regulation of beta 1 and beta 2 subtypes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970414-X

Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970414-X

Effect of beta-blockade on mortality in patients with heart failure: a meta-analysis of randomized clinical trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970414-X

Early reduction of neurohumoral factors plays a key role in mediating the efficacy of beta-blocker therapy for congestive heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970414-X

Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy. Metoprolol in Dilated Cardiomyopathy (MDC) Trial Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970414-X

Increased beta-receptor density and improved hemodynamic response to catecholamine stimulation during long-term metoprolol therapy in heart failure from dilated cardiomyopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970414-X

Why do patients with congestive heart failure tolerate the initiation of beta-blocker therapy?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970414-X

Changing mortality in dilated cardiomyopathy. The Heart Muscle Disease Study Group.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970414-X

Prognostic importance of atrial natriuretic peptide in patients with chronic heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970414-X

Brain natriuretic peptide as a novel cardiac hormone in humans. Evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970414-X

Comparison of atrial natriuretic peptide B-type natriuretic peptide, and N-terminal proatrial natriuretic peptide as indicators of left ventricular systolic dysfunction.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970414-X

Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970414-X

X-linked dilated cardiomyopathy. Molecular genetic evidence of linkage to the Duchenne muscular dystrophy (dystrophin) gene at the Xp21 locus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970414-X

The causes of dilated cardiomyopathy: a clinicopathologic review of 673 consecutive patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970414-X

Severe hypotension after first dose of enalapril in heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970414-X

Angiotensin-converting enzyme inhibitors and renal function in heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970414-X

Cardiomyopathy and pulmonary emboli in terminal Duchennne's muscular dystrophy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970414-X

Discrepancy between systolic and diastolic dysfunction of the left ventricle in patients with Duchenne muscular dystrophy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970414-X

Echocardiography in duchenne muscular dystrophy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970414-X

A comparative study of thallium-201 single-photon emission computed tomography and electrocardiography in Duchenne and other types of muscular dystrophy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970414-X

Value of natriuretic peptides in assessment of patients with possible new heart failure in primary care

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970414-X

Exercise hemodynamics and myocardial metabolism during long-term beta-adrenergic blockade in severe heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970414-X

Left ventricular dilatation and the risk of congestive heart failure in people without myocardial infarction.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970414-X

10.1016/S0002-8703(99)70414-X

7 January 2021

Identifiers

DOI

1 reference

9 February 2018

PubMed ID

10220639

1 reference

9 February 2018